Macular Disease Foundation Australia logo

    Media Type: Media release

    New treatment for Geographic Atrophy

    The Therapeutic Goods Administration (TGA) approval of the new eye injection treatment SYFOVRE® (pegcetacoplan) is welcome news, as it will give many people with Geographic Atrophy a treatment option that they’ve never had before to slow the progression of the disease.

    Read More
    New Nutrition Guidelines for AMD

    New findings reveal that consuming more than 12g of alcohol per day (less than one large glass of wine or large beer) is linked to a higher risk of developing irreversible vision loss; new nutrition guidelines released to help protect Australians’ eyesight.

    Read More
    Loading...